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Abstract
Background: The rapid identification of acid-fast bacilli recovered from patient specimens as Mycobacterium
tuberculosis complex (MTC) is critically important for accurate diagnosis and treatment. A thin-layer
immunochromatographic (TLC) assay using anti-MPB64 or anti-MPT64 monoclonal antibodies was developed
to discriminate between MTC and non-tuberculosis mycobacteria (NTM). Capilia TB-Neo, which is the improved
version of Capilia TB, is recently developed and needs to be evaluated.
Methods: Capilia TB-Neo was evaluated by using reference strains including 96 Mycobacterium species
(4 MTC and 92 NTM) and 3 other bacterial genera, and clinical isolates (500 MTC and 90 NTM isolates).
M. tuberculosis isolates tested negative by Capilia TB-Neo were sequenced for mpt64 gene.
Results: Capilia TB-Neo showed 100% agreement to a subset of reference strains. Non-specific reaction to
M. marinum was not observed. The sensitivity and specificity of Capilia TB-Neo to the clinical isolates were 99.4%
(99.6% for M. tuberculosis, excluding M. bovis BCG) for clinical MTC isolates and 100% for NTM isolates tested,
respectively. Two M. tuberculosis isolates tested negative by Capilia TB-Neo: one harbored a 63-bp deletion in
the mpt64 gene and the other possessed a 3,659-bp deletion from Rv1977 to Rv1981c, a region including the
entire mpt64 gene.
Conclusions: Capilia TB-Neo is a simple, rapid and highly sensitive test for identifying MTC, and showed better
specificity than Capilia TB. However, Capilia TB-Neo still showed false-negative results with mpt64 mutations.
The limitation should be recognized for clinical use.
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Background
Tuberculosis remains a major threat to global health, and
therefore, rapid identification of the causative M. tubercu-
losis complex (MTC) is critical. Liquid culture detection is
now widely used for managing HIV-co-infected and drug-
resistant tuberculosis, and liquid culture can improve
the recovery of acid-fast bacilli and decreases the time
to detection. However, because other non-tuberculosis
mycobacterium (NTM) species may also grow, it is
important to identify MTC from positive culture for
rapid and appropriate management of tuberculosis.
Several methods are available to identify mycobacteria.
Conventional biochemical tests are generally time-con-
suming [1,2] and not surely reproducible, while more
recently developed techniques involving molecular biology
[3-7] or high-performance liquid chromatographic ana-
lysis of mycolic acid [8] are accurate and rapid, but these
require expensive devices. In contrast, immunochromato-
graphic species identification tests, Capilia TB (TAUNS,
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Izunokuni, Japan), SD BIOLINE TB Ag MPT64 rapid
(Standard Diagnostics, Inc., Korea) and BD MGIT™ TBc
Identification Test (Becton, Dickinson and Company,
USA) have been adopted as a cheap, rapid, and accurate
alternative in clinical laboratories around the world
[9-11]. However, false positives to Mycobacterium mari-
num, Staphylococcus aureus [9,12], and false negatives in
MPB64 mutants [10,13] have occasionally been reported.
Capilia TB-Neo (TAUNS, Izunokuni, Japan), an improved
version of Capilia TB, has recently been developed to
overcome these problems. In this study, we evaluated the
performance of Capilia TB-Neo with reference strains and
clinical isolates. Any false-negative MTC clinical isolate
detected by Capilia TB-Neo were further investigated
relative genes.
Methods
Reference strains and clinical isolates
Reference strains of 96 Mycobacterium species and sub-
species (4 MTC and 92 NTM) and 3 other genera with
acid-fastness (Nocardia asteroids, Rhodococcus equi and
Rhodococcus aichiense) were used for the evaluation
(Table 1). A total of 500 MTC and 90 NTM clinical iso-
lates (10M. abscessus, 4M. chelonae, 13M. fortuitum, 8
M. gordonae, 15M. avium complex, 7M. intracellulare,
3M. nonchromogenicum, 5M. scrofulaceum, 4M. xenopi,
15M. kansasii, 1M. gastri, 2M. peregrinum, 1M. inter-
medium, 1M. szulgai, and 1M. marinum) were selected
to provide a representative sample of the isolates available
from Miroku Medical Laboratory Co., Ltd. (Saku, Japan)
from 2009 to 2010, and the collection from the Ryoken
survey in 2002 and 2007. The clinical isolates were
collected from patients as a part of routine examination.
No ethical approval was required for this type of labora-
tory based study only using isolates. Reference strains and
clinical isolates were cultured with OADC-supplemented
Middlebrook 7H9 broth (Becton, Dickinson and Company,
USA) and 2% Ogawa medium (Kyokuto Pharmaceutical
Industrial Co., Japan) at 37°C or 30°C.
Identification of mycobacteria
Mycobacterium species of the clinical isolates were iden-
tified using one or more of the following approaches: (i)
the DNA or RNA amplification kits Cobas Amplicor PCR
(Roche Diagnostics, Japan) and TRC Rapid (Tosoh Bio-
science, Japan); (ii) the DNA-DNA hybridization DDH
Mycobacteria Kit (Kyokuto Pharmaceutical Industrial Co.,
Japan); and (iii) 16S rRNA gene sequencing, supplemen-
tary [7]. The isolates identified as MTC were further
examined by multiplex PCR analysis of cfp32, the region
of difference (RD) 9, and RD12 according to the method
of Nakajima et al. [14]. When MTC species other than M.
tuberculosis sensu stricto were detected, they were further
characterized with respect to RD1, RD4, RD7, and MiD3
[15]. If M. bovis Bacillus Calmette-Guerin (BCG) was
identified, additional multiplex PCR analyses were per-
formed to test for RD2, RD14, RD15, RD16, and SenX3-
RegX3 to distinguish sub-strains of BCG [16,17]. The
multiplex PCR amplification was performed using a Type-
it Microsatellite PCR Kit (QIAGEN, Japan). Each PCR
reaction contained 1.0 μl of DNA template, 6.25 μl of
Type-it multiplex PCR Master mix, 1.25 μl of Q-solution,
0.25 μl of each primer (10 pmol/μl) and an appropriate
amount of molecular grade water for a total reaction
volume of 13 μl. The thermal profile was as follows:
(i) 95°C (5 min); (ii) 28 cycles of 95°C (0.5 min), 58
or 55°C (1.5 min), 72°C (0.5 min); and (iii) a final exten-
sion step at 68 or 60°C (10 or 30 min). The amplified
products were analyzed by 3% agarose gel electrophoresis.
The expected RD loci for each MTC species are summa-
rized in Table 2.
Capilia TB-Neo, SD MPT64, and TBc ID
The validation of Capilia TB-Neo (TAUNS, Izunokuni,
Japan) was conducted using the aforementioned refer-
ence strains as well as MTC and NTM clinical isolates.
In addition, SD BIOLINE TB Ag MPT64 rapid (SD
MPT64: Standard Diagnostics, Inc. Korea) and BD
MGIT™ TBc Identification Test (TBc ID: Becton, Dickin-
son and Company, USA), detect MPT64 which is the same
as MPB64, were tested using reference strains and NTM
clinical isolates. Each test was performed according to the
manufacturer’s instructions. Briefly, clinical isolates grow-
ing on Ogawa medium were suspended in 1 ml of sterile
distilled water, and the suspension subjected to the test.
Similarly, positive liquid cultures of reference strains
(McFarland No. 1 to 2) were directly subjected to each test.
Positive test results were indicated by a red line in the test
area after 15 min.
Sequencing of the mpt64 gene
Any false-negative M. tuberculosis isolate detected by
Capilia TB-Neo was further analyzed by sequencing
mpt64 and surrounding genes by using the primers listed
in Table 2. Each PCR reaction contained 1.0 μl of DNA
template, 12.5 μl of Type-it multiplex PCR Master mix,
2.5 μl of Q-solution, 0.5 μl of each primer (10 pmol/μl)
and an appropriate amount of molecular grade water for a
total reaction volume of 25 μl. The thermal profile was as
follows: (i) 95°C (5 min); (ii) 30 cycles of 95°C (0.5 min),
62°C (1.5 min), 72°C (1 min); and (iii) final extension at
60°C (10 min). The amplified product was analyzed by 3%
agarose gel electrophoresis and was purified using Mag
Extractor (TOYOBO, Japan). The purified DNA products
were subjected to direct sequencing using an ABI 377 auto-
matic sequencer (Applied Biosystems, USA) and BigDye
Terminator Cycle Sequencing v 3.1 (Applied Biosystems,
USA), according to the manufacturer’s instructions. DNA
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M. tuberculosis H37Rv ATCC27294 + + + M. interjectum ATCC51457 - - -
M. africanum ATCC25420 + + + M. intermedium ATCC51848 - - -
M. bovis ATCC19210 + + + M. intracellulare ATCC13950 - - -
M. microti ATCC19422 + + + M. kansasii ATCC12478 - - -
M. abscessus ATCC19977 - - - M. kubicae ATCC700732 - - -
M. acapulcensis ATCC14473 - - - M. lactis ATCC27356 - - -
M. agri ATCC27406 - - - M. lentiflavum ATCC51985 - - -
M. aichiense ATCC27280 - - + M. madagascariense ATCC49865 - - -
M. alvei ATCC51304 - - - M. malmoense ATCC29571 - - -
M. asiaticum ATCC25276 - - - M. marinum ATCC00927 - - +
M. aurum ATCC23366 - - - M. moriokaense ATCC43059 - - -
M. austroafricanum ATCC33464 - - - M. mucogenicum ATCC49650 - - -
M. avium subsp. avium ATCC25291 - - - M. neoaurum ATCC25795 - - -
M. avium subsp. paratuberculosis ATCC19698 - - - M. nonchromogenicum ATCC19530 - - -
M. avium subsp. “suis” ATCC19978 - - - M. novum ATCC19619 - - -
M. avium subsp. silvaticum ATCC49884 - - - M. obuense ATCC27023 - - -
M. branderi ATCC51789 - - - M. paraffinicum ATCC12670 - - -
M. brumae ATCC51384 - + - M. parafortuitum ATCC19686 - - -
M. celatum ATCC51131 - - - M. peregrinum ATCC14467 - - -
M. celatum II ATCC51130 - - - M. petroleophilum ATCC21497 - - -
M. chelonae chemovar niacinogenes ATCC35750 - - - M. phlei ATCC11758 - - -
M. chelonae subsp. chelonae ATCC35752 - - - M. porcinum ATCC33776 - - -
M. chitae ATCC19627 - - + M. poriferae ATCC35087 - - -
M. chlorophenolicum ATCC49826 - - - M. pulveris ATCC35154 - - -
M. chubuense ATCC27278 - - - M. rhodesiae ATCC27024 - - -
M. confluentis ATCC49920 - - - M. scrofulaceum ATCC19981 - - -
M. conspicuum ATCC700090 - - - M. senegalense ATCC35796 - - -
M. cookii ATCC49103 - - - M. septicum ATCC700731 - - -
M. diernhoferi ATCC19340 - - - M. shimoidei ATCC27962 - - -
M. duvalii ATCC43910 - - - M. shinshuense ATCC33728 - - -
M. engbaekii ATCC27353 - - - M. simiae ATCC25275 - - -
M. flavescens ATCC14474 - - - M. smegmatis ATCC19420 - - -
M. fortuitum subsp. acetamidolyticum ATCC35931 - - - M. smegmatis ATCC700084 - - -
M. fortuitum subsp. fortuitum ATCC06841 - - - M. sphagni ATCC33027 - - -
M. fortuitum subsp. fortuitum ATCC49403 - - - M. szulgai ATCC35799 - - -
M. gadium ATCC27726 - - + M. terrae ATCC15755 - - -
M. gallinarum ATCC19710 - - - M. terrae DSMZ43540 - - -
M. genavense ATCC51234 - - - M. terrae DSMZ43541 - - -
M. gilvum ATCC43909 - - - M. terrae DSMZ43542 - - -
M. goodii ATCC700504 - - - M. thermoresistibile ATCC19527 - - -
M. gordonae ATCC14470 - - - M. tokaiense ATCC27282 - - -
M. gordonae group B19 KK33-08 - - - M. triplex ATCC700071 - - -
M. gordonae group C19 KK33-53 - - - M. triviale ATCC23292 - - -
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sequences of mpt64 from each isolate were compared
with M. tuberculosis H37Rv by using Genetyx-win ver. 5.2
(Genetyx Co., Japan).
Results
Each of the three kits (Capilia TB-Neo, SD MPT64, and
TBc ID) was tested using the 99 reference strains. Capilia
TB-Neo correctly produced positive results for four MTC
(M. tuberculosis, M. africanum, M. bovis, and M. microti)
and negative results for 92 NTM and 3 non-mycobacterial
species (other genera) with acid-fastness, while SD MPT64
and TBc ID generated several false positives (Table 1).
The sensitivity and specificity of Capilia TB-Neo to refer-
ence strains were 100%.
Of the 500 MTC clinical isolates tested, 497 were
identified as MTC by Capilia TB-Neo. The other 3
isolates that tested negative by using Capilia TB-Neo
also tested negative by using SD MPT64 and TBc ID.
All three kits produced negative results for all 90 NTM
clinical isolates examined. Thus, The sensitivity and spe-
cificity of Capilia TB-Neo to the clinical isolates were
99.4% and 100%, respectively.
The multiplex PCR system identified 492M. tubercu-
losis isolates out of 500. Five isolates, which were cfp32-,
RD9-, RD4-, RD7-, and MiD3-positive, but RD12-nega-
tive, were initially identified as M. canettii. However, col-
onies of these isolates showed a consistent rough surface
on solid medium, and subsequent sequencing of hsp65
indicated that the isolates had the genotype of M. tuber-
culosis sensu stricto (data not shown). These isolates were
collected from different areas of Japan. Consequently, 497
isolates were identified as M. tuberculosis. The remaining
3 isolates were deficient in RD1, RD4, RD7, RD9, and
RD12, and therefore were identified as M. bovis BCG.
Two of these isolates were confirmed as M. bovis BCG
Tokyo based on the unique size of RD16, and the third
isolate had the same RD pattern as BCG Connaught and
BCG Montreal, as for RD2, RD14, RD15, RD16 and
SenX3-RegX3 (Figure 1). Among the 3 MTC isolates that
tested negative by Capilia TB-Neo, 2 isolates were M.
tuberculosis and the other was M. bovis BCG Connaught
or BCG Montreal (Table 3).
Mutations in the mpt64 gene were detected by
sequencing two M. tuberculosis isolates with negative
results by Capilia TB-Neo. One isolate had a deletion of
63 bp from nucleotides 196 to 258 (amino acids position
43 to 63), and the other had a deletion of 3,659 bp from
nucleotide 874 in Rv1977 to nucleotide 905 in Rv1981c,
which included the whole mpt64 gene.
Discussion
In many industrialized countries, the ability to rapidly
distinguish between MTC and NTM is critical in clinical
practice. Indeed, the anti-tuberculosis drug resistance sur-
vey in Japan revealed that 19.3% of all clinical mycobacterial
isolates are NTM [18], underscoring the importance of
rapid and accurate detection of MTC from acid-fast bacil-
lus-positive culture. The immunochromatographic assay kit
for the identification of MTC is now widely used in
many countries. Capilia TB-Neo is the improved version
of Capilia TB, and has been subjected to few clinical evalu-
ations. Here, we report good overall performance of the
kit but with several limitations.
In this study, the sensitivity of Capilia TB-Neo was
99.4% to clinical MTC isolates or 99.6% excluding M.
bovis BCG, while the specificity of the kit tested to
clinical NTM isolates was 100%. However, the isolation
of BCG could present a practical problem. The M. bovis
BCG Tokyo strain is sporadically isolated in Japan as a
complex of vaccination or bladder cancer therapy, and is
identified as MTC with the kit [19]. Some BCG strains
such as Connaught, Pasteur, and Tice lack RD2 includ-
ing the mpt64 gene, but RD2 is conserved in others such
as Tokyo, Moreau, and Russia [16]. This issue should be
properly addressed to avoid confusion. Although it is
difficult to discriminate BCG Tokyo from MTC with
mpt64/mpb64, their differentiation would be an import-
ant advance in the development of a future TLC product.
The weak false-positive reaction to M. marinum that was
reported using Capilia TB [12] was not observed in this
study, and resulted in better specificity. The minimum
Table 1 List of reference strains and the results of identification of MTC by using Capilia TB-Neo, SD MPT64, and TBc ID
(Continued)
M. gordonae group D19 KK33-46 - - - M. vaccae ATCC15483 - - -
M. haemophilum ATCC29548 - - - M. valentiae ATCC29356 - - -
M. hassiacum ATCC700660 - - - M. wolinskyi ATCC700010 - - -
M. heckeshornense DSMZ44428 - - - M. xenopi ATCC19250 - - -
M. heidelbergense ATCC51253 - - - Nocardia asteroides ATCC19247 - - -
M. hiberniae ATCC49874 - - - Rhodococcus equi ATCC6939 - - -
Rhodococcus aichiense ATCC33611 - - -
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detection concentration of M. tuberculosis for Capilia
TB-Neo was 105 CFU/ml (data not shown), which was
one-tenth than that for the previous kit. There was a re-
port that Cpilia TB-Neo was higher sensitivity than Capilia
TB [20]. In summary, the overall performance of Capilia
TB-Neo was better than Capilia TB in both sensitivity and
specificity.
SD MPT64 and TBc ID were also tested with reference
strains. Both SD MPT64 and TBc ID showed false-positive
results against several NTM strains in this study. Kodama
et al. [12] reported that no M. marinum strains
grown on 2% Ogawa medium tested positive by using
the Capilia TB, while all strains grown on 3 kinds of
liquid medium, MGIT (Becton Dickinson, Japan), KRD
Table 2 Oligonucleotide primers used in PCR and direct sequencing
Target gene Primer ID Nucleotide sequence (5'-3') Size (bp) Ref. no.
MTC identification
16S rRNA 285 GAGAGTTTGATCCTGGCTCAG 1028 7
264 TGCACACAGGCCACAAGGGA
259 TTTCACGAACAACG GACAA 591
cfp32 Rv0577F ATGCCCAAGAGAAGCGAATACAGGCAA 786 14
Rv0577R CTATTGCTGCGGTGCGGGCTTCAA
RD9 Rv2073cF TCGCCGCTGCCAGATGAGTC 600 14
Rv2073cR TTTGGGAGCCGCCGGTGGTGATGA
RD12 Rv3120F GTCGGCGATAGACCATGAGTCCGTCTCCAT 404 14
Rv3120R GCGAAAAGTGGGCGGATGCCAG
RD1 ET1 AAGCGGTTGCCGCCGACCGACC 15
ET2 CTGGCTATATTCCTGGGCCCGG
ET3 GAGGCGATCTGGCGGTTTGGGG
RD4 Rv1510F GTGCGCTCCACCCAAATAGTTGC 1033 15
Rv1510R TGTCGACCTGGGGCACAAATCAGTC
RD7 Rv1970F GCGCAGCTGCCGGATGTCAAC 1116 15
Rv1970R CGCCGGCAGCCTCACGAAATG
MiD3 IS1561F GCTGGGTGGGCCCTGGAATACGTGAACTCT 530 15
IS1561R AACTGCTCACCCTGGCCACCACCATGGACT
Distinguish sub-strains of BCG
RD2 RD2l CCAGATTCAAATGTCCGACC 16
RD2r GTGTCATAGGTGATTGGCTT
RD14 RD14l CAGGGTTGAAGGAATGCGTGTC 16
RD14r CTGGTACACCTGGGGAATCTGG
RD15 RD8l ACTCCTAGCTTTGCTGTGCGCT 16
RD8r GTACTGCGGGATTTGCAGGTTC
RD16 RD16nf ACATTGGGAAATCGCTGCTGTTG 17
RD16nr GGCTGGTGTTTCGTCACTTC
SenX3-RegX3 C3 GCGCGAGAGCCCGAACTGC 16
C5 GCGCAGCAGAAACGTCAGC
Sequencing
mpt64 (Rv1980c) mpb64W-F ACTCAGATATCGCGGCAATC 1061 this study
mpb64W-R CGATCACCTCACCTGGAGTT
Rv1977 Rv1977F GTTTCCCGAGATCAGCTCAA 348 this study
Rv1977R ATCTCGTCGTGTGTCACCAG
Rv1981c Rv1981F GATCGAATGCAGGCTGGTAT 399 this study
Rv1981R ACTACTACCGCGGTGACGAC
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medium (Japan BCG Laboratory, Japan) and Myco Acid
(Kyokuto Pharmaceutical Industrial Co. Ltd., Japan), even-
tually displayed a positive reaction that intensified
with time. Kodama et al. speculated that nonspecific
antigen which could make complex with anti-MPB64
antibody may be produced in liquid mediums, but
not on solid medium. Considering the effect of liquid
culture, the original bacterial suspensions giving false-
positive results, that were prepared from liquid and
solid culture, were then re-tested before and after 10-fold
dilution. Interestingly, none of these diluted strains
tested positive in these kits, but bacterial concentra-
tions were high enough for positive results in case of
MTC. These results implied that a high concentra-
tion of bacterial antigens could induce non-specific
reactions in SD MPT64 and TBc ID. The manufac-
turer’s instructions for the TBc ID indicate that this
kit may be used up to 10 days after a positive MGIT
alarm. This non-specific reaction should be properly
addressed in clinical practice, and the users should
perform morphological characterization with a micro-
scope to identify cord formation.
Several mutations in the mpt64 gene produce a nega-
tive test result for M. tuberculosis isolates in the TLC
assay using anti-MPB64 monoclonal antibodies. To date,
these include a 63-bp deletion from nucleotide 196, a
1-bp deletion from nucleotide 266, a point mutation
at position 388 or 402, IS6110 insertion mutation at
position 177 or 501, a 176-bp deletion from nucleo-
tide 512, and a 1-bp insertion at position 287 [10,13,21].
In our study, 2M. tuberculosis isolates gave false-negative
results by using the Capilia TB-Neo, SD MPT64, and TBc
ID. One isolate had a deletion of 63 bp from nucleotide
196 in the mpt64 gene as reported previously, and the
other isolate possessed a 3,659-bp deletion from nucleo-
tide 874 in Rv1977 to 905 in Rv1981c, including the whole
mpt64 gene. To the best of our knowledge, this is the first
report of a large deletion in mpt64. A transposon site
hybridization (TraSH) study [22] indicated that mpt64
is not essential for infection or in vitro growth of M.
tuberculosis. This large deletion mutant supported the
finding.
In summary, the TLC assay detecting MPB64 or
MPT64 can be applied to specimens prepared from li-
quid and solid culture. It does not need special reagents,
instruments, or complex techniques. Capilia TB-Neo
tested in this study showed excellent sensitivity with per-
fect specificity.
Conclusions
Capilia TB-Neo showed high sensitivity and specificity
with clinical mycobacterial isolates, and 100% specifi-
city to reference strains. However, 2M. tuberculosis
isolates were tested negative by Capilia TB-Neo be-
cause of mutations in the mpt64 gene, and positive to
certain BCG sub-strain. This study, therefore, serves
to emphasize the importance of careful use of the kit
and the complementary techniques such as morpho-
logical identification.
Figure 1 Multiplex PCR analysis of Mycobacterium bovis BCG
sub-strains and clinical isolates. 1: BCG Pasteur (ATCC35734), 2:
BCG Glaxo (ATCC35741), 3: BCG Copenhagen (ATCC27290), 4: BCG
Russian (ATCC35740), 5: BCG Montreal (ATCC35735), 6: BCG Connaught
(ATCC35745), 7: BCG Danish, 8: BCG Tokyo, 9: Sample 421, 10: Sample
467, 11: Sample 475, M: Size marker.
Table 3 Results of PCR detection and Capilia TB-Neo of MTC with clinical isolates
Species interpretation (Number of isolates) Banding pattern Capilia TB-Neo %
cfp32 RD9 RD12 RD4 RD7 MiD3 RD1
M. tuberculosis (490) + + + NT NT NT NT + 98.0
M. tuberculosis (2) + + + NT NT NT NT - 0.4
"M. canettii" (5)a + + - + + + + + 1.0
M. bovis BCG Tokyo (2)b + - - - - + - + 0.4
M. bovis BCG Connaught (1)c + - - - - + - - 0.2
aConfirmed to be M. tuberculosis by hsp65 sequencing and morphology, bConfirmed by contracted RD16, cConfirmed by absence of RD2 and RD15, and contracted
SenX3-RegX3, NT: Not tested.
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